Conversations with CEI – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Conversations with CEI

Clinical Education Initiative

Education

Health & Fitness

Science

Frequency: 1 episode/29d. Total Eps: 72

Conversations with Clinical Education Initiative (CEI) features clinical experts in HIV Primary Care and Prevention, Sexual Health, Hepatitis C and Drug User Health. Our episodes feature CEI clinicians’ experience and insight on the current health issues, alongside the latest news and guidelines on our areas of expertise.

This podcast is produced by the CEI, a New York State Department of Health AIDS Institute program.

Read moreCollapse

Site

RSS

Apple

Data updated on 26/09/2026

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://doi.org/10.1186/s12954-017-0196-4
6 shares
https://doi.org/10.1002/cld.921
4 shares
https://doi.org/10.1093/cid/ciad511
2 shares

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 58%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Anabolic Androgenic Steroids: Is “The Cycle” Addictive?

Episode 71

Thursday, September 24, 2026 • Duration 21:45

Anabolic androgenic steroids (AAS) are synthetic versions of testosterone, and like naturally produced testosterone, they can increase male sex characteristics and help build muscle. They are prescribed for low testosterone, delayed puberty and muscle loss from severe illness, among other things. But AAS are also used regularly – particularly among gay, bisexual and queer men – without a prescription to gain muscle and improve physical appearance.

The health impact of use varies from injection-site infection to sexual dysfunction and high blood pressure, and many people who use AAS have developed creative ways to mitigate risk. Today’s episode will introduce AAS as performance enhancing drugs and provide harm reduction strategies that clinicians can employ to mitigate risks associated with their use. Related content:

Kutscher E, Arshed A, Greene RE, Kladney M. Exploring Anabolic Androgenic Steroid Use Among Cisgender Gay, Bisexual, and Queer Men. JAMA Netw Open. 2024 May 1;7(5):e2411088. doi: 10.1001/jamanetworkopen.2024.11088.
Kutscher E, Arshed A, Greene R, Kladney M. Exploring Anabolic-Androgenic Steroids Use Among Cisgender Gay, Bisexual, and Queer Men. Drug and Alcohol Dependence. 2025 Feb 1;267:112112.
Kutscher E, Arshed A, Greene RE, Kladney M. Harm Reduction Techniques among Cisgender Gay, Bisexual, and Queer Men Using Anabolic Androgenic Steroids: A Qualitative Study. Harm Reduction Journal. 2024;21:196. doi.org/10.1186/s12954-024-01121-8.
Kutscher E, Silverman E, Bachi K. Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy. Focus (Am Psychiatr Publ). 2026 Spring;24(2):168-178. doi: 10.1176/appi.focus.20250045.
Clinical decision tool for providers and patients: https://aas-87py.onrender.com/#/providers/
CEI Line: 1-866-637-2342
https://ceitraining.org/

Read moreCollapse

AIDS 2026 in Rio: What Came Out of the 26th International AIDS Conference

Episode 70

Thursday, September 10, 2026 • Duration 17:05

AIDS 2026, the 26th International AIDS Conference, was held on July 26-31 in Rio. In this episode, Dr. Antonio E. Urbina, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, summarizes the clinical highlights from AIDS 2026, focusing on new HIV treatments and prevention strategies. Related content:

CEI Line: 1-866-637-2342
https://ceitraining.org/
https://www.iasociety.org/conferences/aids2026

Read moreCollapse

Updates on HSV Infection

Episode 69

Thursday, August 27, 2026 • Duration 22:45

Daniela DiMarco, MD, MPH is joined by guest speaker Valeria Cantos, MD for this episode of “Conversations with CEI.” Dr. Valeria Cantos is an Associate Professor at the Division of Infectious Diseases at Emory. She is an investigator at the Emory Ponce Clinical research site, where she leads HIV prevention and HIV vaccine clinical trials from the HPTN and HVTN networks. Herpes simplex virus (HSV) infection is one of the most common STIs worldwide. This episode covers a brief overview of herpes simplex virus (HSV) mucocutaneous infections including current recommendations for testing, diagnosis, treatment, and preventing perinatal HSV transmission. They also discuss managing more challenging scenarios to provide practical guidance and address common clinical questions. Related Content:

CEI Line: 1-866-637-2342
www.ceitraining.org
www.hivguidelines.org
Plunkett M, Neville CT, Chang JG. Genital Herpes: Rapid Evidence Review. Am Fam Physician. 2024 Nov;110(5):487-492. PMID: 39556630.
Gnann JW Jr, Whitley RJ. CLINICAL PRACTICE. Genital Herpes. N Engl J Med. 2016 Aug 18;375(7):666-74. doi: 10.1056/NEJMcp1603178. PMID: 27532832.
Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2023 Jan 27;72(4):107-108. doi: 10.15585/mmwr.mm7204a5. PMID: 34292926; PMCID: PMC8344968.

Read moreCollapse

Beyond the Script: Applying Harm Reduction Principles in Practice

Episode 68

Thursday, August 13, 2026 • Duration 46:51

Communication and relationship building are key approaches to harm reduction that focus on meeting people where they are. Both rely on shifting away from stigma and bias to create a safe, open dialogue between patient and provider that builds trust and autonomy while prioritizing safety and dignity. Clinical guidelines on how to effectively implement these principles of harm reduction to affect incremental, positive change exist, but can be difficult to translate into practice.

This episode features two New York City-based nurses who are passionate about harm reduction and strive to bring its principles to all care settings. In partnership with another colleague, they developed a harm reduction tool to help providers navigate the sometimes opaque work of harm reduction in clinical spaces. Guests will introduce the tool, discuss the complexities of practicing harm reduction medicine and provide concrete strategies to integrate harm reduction into every clinical encounter. Related Content:

CEI Line: 1-866-637-2342
https://ceitraining.org/
CEI Training, Integrating Harm Reduction into Every Clinical Encounter: https://ceitraining.org/courses/1597
New York State Department of Health Clinical Guidelines for Substance Use Harm Reduction in Medical Care: https://www.hivguidelines.org/guideline/substance-use-harm-reduction/
New York State Office for Addiction Services and Supports (OASAS) Harm Reduction: https://oasas.ny.gov/harm-reduction
National Harm Reduction Coalition: https://harmreduction.org/
Hawk, M., Coulter, R.W.S., Egan, J.E., et al. (2017). Harm reduction principles for healthcare settings. Harm Reduct J. 14(70). doi: https://doi.org/10.1186/s12954-017-0196-4

Cardiovascular Risk in People with HIV: New Risk Equations, New Guidelines, and Who Gets a Statin

Episode 67

Thursday, July 23, 2026 • Duration 17:26

The 2026 ACC/AHA/Multisociety Dyslipidemia Guideline recommends statin therapy for primary prevention of ASCVD for all people living with HIV (PLHIV) aged 40 to 75 years, independently of their traditional ASCVD risk score. This replaces previous calculator-based thresholds. On this episode, Antonio Urbina, MD, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, outlines the latest cardiovascular health guidelines for persons living with HIV. Related Content:

CEI Line: 1-866-637-2342
https://ceitraining.org/
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia

Read moreCollapse

Best of the Best: Practice-Changing Papers in STI Care from 2025

Episode 66

Thursday, July 9, 2026 • Duration 21:00

Hosts Margie Urban, MD, and Daniela DiMarco, MD, MPH, are joined by Jason Zucker, MD. Dr. Zucker is an Assistant Professor of Medicine at the Columbia University Irving Medical Center and is also the Principal Investigator (PI) and Co-Medical Director of the New York City STD and HIV Prevention Training Center. This podcast gives a snapshot of Dr. Zucker’s review of the most influential STI-related publications of 2025. Dr. Zucker will be giving a presentation, titled STI Management: Top Papers of 2025 That Will Impact Your Management Today or Tomorrow, taking place on July 13, 2026. Additional information can be found at the link below. Related content:

CEI Line: 1-866-637-2342
www.ceitraining.org
www.hivguidelines.org
Webinar registration link (7/13)- STI Management

Read moreCollapse

Compassion, Choice and Curiosity: Harm Reduction in Practice

Episode 65

Thursday, June 25, 2026 • Duration 20:06

Harm reduction is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. It is also a movement for social justice build on a belief in, and respect for, the rights of people who use drugs. Although harm reduction was introduced as a U.S. Federal Drug Policy Priority in 2022, it’s currently facing funding cuts that threaten life-saving resources and services.

In this episode, we’ll hear from harm reductionist Giorgio Handman who has over 15 years’ experience advocating for and implementing harm reduction to support New Yorkers. He will share his personal experience with harm reduction and talk about the evolution and future of harm reduction. Related Content:

Harlem United / History of the Foundation for Research on Sexually Transmitted Disease (FROST’D): https://www.harlemunited.org/frostd-joins-harlem-united-family/
VOCAL New York: https://www.vocal-ny.org/
National Harm Reduction Coalition: https://harmreduction.org/
New York State Office for Addiction Services and Supports (OASAS) Harm Reduction: https://oasas.ny.gov/harm-reduction
Hawk, M., Coulter, R.W.S., Egan, J.E., et al. (2017). Harm reduction principles for healthcare settings. Harm Reduct J. 14(70). doi: https://doi.org/10.1186/s12954-017-0196-4
SAMHSA Dear Colleague Letter: https://www.samhsa.gov/sites/default/files/dear-colleague-letter-upated-hr-funding-guidance.pdf
CEI Line: 1-866-637-2342
https://ceitraining.org/

Closer to a Cure? New HIV Cure Research from Stem Cell Transplants to CAR-T Cell Therapy

Episode 64

Thursday, June 11, 2026 • Duration 10:24

Two recent studies have shown remarkable advances in HIV cure research: (1) a Norwegian man who achieved long-term HIV remission after a stem cell transplant from his brother and (2) a Phase 1 trial testing CAR-T cell therapy. On this episode, Antonio Urbina, MD, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, dives into these studies and puts them into clinical context, including how to discuss cure research with patients. Related Content:

CEI Line: 1-866-637-2342
https://ceitraining.org/
Clinicaltrials.gov

Read moreCollapse

ASSETS-NY – Anal Dysplasia Screening, Surveillance, Education and Treatment Services of NY

Episode 63

Thursday, May 28, 2026 • Duration 22:37

Host Marguerite Urban, MD is joined by William DeWitt, MD, Clinical Director of Anal Health in Primary Care at Northwell Health, to discuss a new coalition forming in New York City about anal dysplasia. ASSETS-NY aims to bring together people in this field and harness momentum to drive further research and implementation of anal dysplasia and cancer screening, surveillance, education and treatment in New York State. Be sure to check out the coalition’s website at https://www.screenyourbutt.org/nyc/. Related Content:

CEI Line: 1-866-637-2342
www.ceitraining.org
www.hivguidelines.org
ASSETS-NY Website: https://www.screenyourbutt.org/nyc/
NYS DOH AIDS Institute, “Screening for Anal Dysplasia and Cancer in Adults With HIV” guidelines: https://www.hivguidelines.org/guideline/hiv-anal-cancer/#toc_wurop7uf
International Anal Neoplasia Society (IANS): https://www.iansoc.org/

Read moreCollapse

Introducing Point-of-Care Testing for Hepatitis C

Episode 62

Thursday, May 14, 2026 • Duration 21:35

New York State’s Hepatitis C Dashboard shows that in 2023, 4,783 people were newly diagnosed with HCV in the state, an 8% decrease from 2022. Incidence also decreased, with the rate of new HCV infections dropping from 4.0 to 3.6 per 100,000 population among adult New Yorkers. Despite these gains, progress towards elimination has been stalled by reliance on a multi-step diagnostic algorithm to confirm viremia. In populations with the highest risk of infection – including people who inject drugs – testing and treatment are often inaccessible due to barriers along the care cascade.

On June 27, 2024, the U.S. Food and Drug Administration authorized the first point-of-care (POC) HCV RNA test that can be performed where a person receives care, like an outpatient clinic or mobile unit. The availability of a POC HCV RNA testing, which can provide a qualitative results in 60 minutes, unlocks New York’s ability to integrate a test-and-treat approach where a person can be tested for HCV, and if positive for HCV RNA, be linked to care and potentially receive treatment during the same health care visit. To achieve elimination goals, simplified care that engaged people who inject drugs is essential, and single encounter testing and treatment offers a new tool to significantly expand access, decrease time from diagnosis to treatment and increase the number of New Yorkers who are treated for HCV.

Today’s episode will focus on this new diagnostic tool and its potential impact on HCV elimination across New York. Related Content:

New York State Department of Health Clinical Guidelines Program, Hepatitis C Virus Screening, Testing, and Diagnosis in Adults (January 2023): https://www.hivguidelines.org/guideline/hcv-testing/?mycollection=hepatitis-care
New York State Department of Health Hepatitis C Dashboard: https://hcvdashboardny.org/
New York State Department of Health, Frequently Asked Questions for Hepatitis C Point of Care Diagnostic Testing (June 2025): https://www.health.ny.gov/diseases/communicable/hepatitis/hepatitis_c/providers/docs/poc_faq.pdf

Conversations with CEI – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Conversations with CEI – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Other99+

CDC21

DOI Foundation10

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Other99+

CDC21

DOI Foundation10